Business News - Pharma - Quartz

Pharma

Transforming health through business and innovation.

Abivax CEO says $920M raise lets it launch its bowel disease drug in the U.S. solo

ByColleen Cabili

Lupin Pharmaceuticals is recalling 2.5 million bottles of prescription steroid eye drops over contamination

ByColleen Cabili

AstraZeneca stock plunges after late-stage heart drug trial misses its target

Kailera's weight loss pill met its trial goal. But nausea hit 70% of patients

ByColleen Cabili

Vera Therapeutics stock jumps after the FDA approved its autoimmune kidney drug

Annovis Bio enrolls over 850 patients for its next Alzheimer's Disease trial

Vertex Pharmaceuticals is buying Crinetics to expand into rare hormonal diseases

Novartis is buying a U.K. cancer drug startup for up to $1.5 billion

Ipsen is acquiring a Swiss biotech for up to $800 million to treat kidney transplant infections

Eli Lilly is handing China sales rights for a breast cancer drug to Innovent Biologics

Abivax stock surges as new trial data ease cancer fears over bowel disease drug

ByColleen Cabili

Congress is investigating Merck and AbbVie over drug trials in China tied to its military

FDA picks Eli Lilly and Regeneron for a program to speed up domestic drug factory reviews

Ipsen is buying U.S. blood cancer startup Kartos for up to $1.75 billion

ByColleen Cabili

Medicare is starting to cover weight loss drugs for some seniors. Here's what to know

SITC’S Dr. James Gulley and Dr. Zhen Su discuss latest cancer drug developments

Chan Zuckerberg Biohub is opening a 4th round of rare disease grants

ByColleen Cabili

FDA's hiring is picking up speed as it works to rebuild after DOGE job cuts

Pfizer's experimental lung cancer drug fails to extend survival in late-stage trial

ByColleen Cabili

FDA is launching a pilot program to shorten early drug trials and counter China

ByColleen Cabili

Facebook X Instagram Youtube RSS Feed

Sitemap About Accessibility Privacy Terms of Service Advertising

© 2026 Quartz Media Network. All Rights Reserved.

Search Newsletters

Home Latest Business News Money & Markets Tech & Innovation A.I.Lifestyle Leadership ✉️ Emails 🎧 Podcasts